Details for 2016751123

Up to date per 04.04.2026

Actions

Title / Product Name

CGRP-REZEPTORANTAGONISTEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016751123

EP Publication Number

3334721

E-Number

1386921

Language

PCT Number

US16045698

Publication Date

20.06.2018 A

28.04.2021 B1

Registration Date

28.04.2021

AT Publication Date

15.05.2021

Application Date

05.08.2016

Registration Number

Priorities

12.08.2015

201562203996 P

14.12.2015

201562266867 P

IPC

C07D 401/12 20060101AFI20170227BHEP

Maximum Duration of Protection

05.08.2036

Owner

Eli Lilly and CompanyLilly Corporate Center Indianapolis, IN 46285US

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

COATES, David Andrewc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, IN 46206-6288US

FORTNER, Kevin Charlesc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, IN 46206-6288US

MASSEY, Steven Marcc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, IN 46206-6288US

MYERS, Jason Kennethc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, IN 46206-6288US

NAVARRO, Antonioc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, IN 46206-6288US

SIEGEL, Miles Goodmanc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, IN 46206-6288US

STUCKY, Russell Deanc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, IN 46206-6288US